Application of autological blood plasma preparations in treatment of adhesive capsulites

The basis of adhesive capsulitis therapy is conservative treatment. Its effectiveness has been proven all over the world and reaches 90%. Adhesive capsulitis therapy is aimed at eliminating pain and inflammation of the joint capsule, which allows to increase the range of motion and muscle strength, as well as improve the patient's quality of life. Currently, the development of cellular technologies has added intra-articular injections of autologous platelet-rich plasma (PRP) to the arsenal of conservative therapy for adhesive capsulitis. As a natural biological stimulant, plasma contains many growth factors secreted by platelets, and therefore acts on various factors in the regenerative process. Materials and methods: 42 patients aged 47 to 60 years with clinically and instrumentally confirmed adhesive capsulitis were treated with intra-articular injections of autologous plasma at the Clinic of Traumatology, Orthopedics and Joint Pathology of the University Clinical Hospital No. 1 of the Sechenov University. Results: the use of autologous blood plasma in the treatment of adhesive capsulitis made it possible to weaken the pain syndrome and increase the amplitude of active movements in the joint at different stages of the disease. Platelet-rich plasma reduced the use of painkillers and anti-inflammatory drugs (p <0.05). Conclusion: in the complex treatment of adhesive capsulitis, autologous plasma relieves pain, helps to restore the range of motion, and reduces the drug load.